search for books and compare prices
Aaron D. Levine has written 3 work(s)
Search for other authors with the same name
displaying 1 to 3 | at end
show results in order: alphabetically | oldest to newest | newest to oldest
Cover for 9781435851689 Cover for 9781851685226 Cover for 9780977853182
cover image for 9781435851689
Product Description: Should we clone extinct or endangered species? Are we justified in using human stem cells from embryos to develop cures? When will we clone the first human? Ever since Dolly the sheep, questions like these have rarely been far from the public consciousness, and cloning is now poised to revolutionize medicine, healthcare, and even the food we eat...read more

Library:

9781435851689 | Rosen Pub Group, January 1, 2009, cover price $38.25 | About this edition: Should we clone extinct or endangered species?

cover image for 9781851685226
Product Description: Should we clone extinct or endangered species? Are we justified in using stem cells to develop cures? When will we clone the first human? Ever since Dolly the sheep, questions like these have rarely been far from the public consciousness, and cloning is now poised to revolutionize medicine, healthcare, and even the food we eat...read more

Paperback:

9781851685226 | Oneworld Pubns Ltd, July 15, 2007, cover price $14.95 | About this edition: Should we clone extinct or endangered species?

cover image for 9780977853182
Product Description: This volume considers the promise and pitfalls of the states' unprecedented venture into the world of scientific research funding. With commentary by Nobel Prize winner Paul Berg and Richard Codey, the path-breaking governor of New Jersey who was among the first to commit his state to funding stem cell research, the book offers readers unique insight into one of the most exciting policy innovations of the 21st century...read more
By Aaron D. Levine (editor)

Paperback:

9780977853182 | Policy Research Inst for the region, January 1, 2006, cover price $14.95 | About this edition: This volume considers the promise and pitfalls of the states' unprecedented venture into the world of scientific research funding.

displaying 1 to 3 | at end